Therma Bright announced that Horizon Health has purchased an additional 100 units of its Venowave™ mobile compression device, doubling their initial order made in March 2026. This follow-up order highlights strong demand for Venowave™ among Horizon's vascular patients, supported by positive clinical feedback and effective distribution channels. Therma Bright expects this to be the foundation for a significant long-term revenue stream as Horizon Health plans to increase order frequency and volume throughout the year. Venowave™ is a compact device designed to improve blood flow and prevent blood clots, reimbursed under Medicare in the U.S., and is gaining traction in vascular care protocols.
Dr. Dajun Yang, Chairman and CEO of Ascentage Pharma, was ranked No. 3 on The Medicine Maker Power List 2026 in the Small Molecules category, recognizing his leadership in oncology drug development. Under his guidance, Ascentage Pharma has advanced i...
Charles Hoskinson, co-founder of Cardano, warned that Bitcoin might lose its top cryptocurrency status if its governance structure fails to effectively address quantum computing challenges. He emphasized that Bitcoin's rigidity in making major upgrad...
Toescoin, a memecoin on the Solana blockchain, announced talks with a major Japanese venture capital firm interested in investing up to $250,000 over time. This engagement aims to provide both funding and strategic support as Toescoin expands its pre...
Singapore's Monetary Authority has slightly increased the rate of appreciation of the Singapore dollar's policy band for the second time, aiming to preempt inflation risks from rising oil prices. Despite core inflation remaining low at 1.6% in June, ...
POSCO International, South Korea's largest trading company, is piloting the tokenization of real commercial invoices on the Injective blockchain in partnership with LG CNS. This pilot creates a unified, transferable onchain record for trade receivabl...
